RUC-4 is a selective antagonist of the integrin alphaIIbbeta3, which inhibits platelet aggregation. It is investigated for prehospital treatment of myocardial infarction. Research applications include in vitro platelet function studies and in vivo models of thrombosis and arterial injury.
Molekulargewicht:
386.43
CAS Nummer:
[1448313-27-6]
Formel:
C16H18N8O2S
Target-Kategorie:
Others,Integrin
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten